China in vitro fertilization (IVF) market size is projected to exhibit a growth rate (CAGR) of 17.18% during 2025-2033. The changing societal attitudes and perceptions toward infertility in China, several advancements in medical technology, and the implementation of supportive policies for encouraging family planning and supporting couples seeking fertility treatments with financial incentives represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Growth Rate (2025-2033) | 17.18% |
In vitro fertilization in China, is a medical procedure that assists couples or individuals in achieving pregnancy when conventional methods are unsuccessful. This advanced reproductive technology is gaining significant recognition and utilization in China over the past few decades, addressing infertility concerns and offering new hope to those seeking to start or expand their families. in vitro fertilization (IVF) process begins with the collection of eggs from the female partner, or donor, and sperm from the male partner or a sperm donor which are then, combined in a laboratory dish to facilitate fertilization. Once fertilization occurs, the resulting embryos are nurtured and monitored carefully for several days. The strongest and healthiest embryos are selected for transfer into the uterus. This implantation is an essential step in the procedure, as its success determines whether a pregnancy will ensue. It is known for its advanced technology and skilled medical professionals. The country offers advanced fertility clinics and hospitals equipped with the latest equipment and staffed by experienced specialists. These facilities adhere to rigorous quality and safety standards to ensure the well-being of patients throughout the in vitro fertilization (IVF) journey. Nowadays, China's in vitro fertilization (IVF) services also stand out due to their affordability compared to many Western countries.
The market is primarily driven by the changing societal attitudes and perceptions toward infertility in China. In addition, the shift toward greater openness and acceptance of infertility as a medical condition led more couples to seek fertility treatments, including in vitro fertilization (IVF), as a viable option for building their families, influencing market growth. Moreover, several advancements in medical technology and rising awareness of in vitro fertilization (IVF) procedures made it a more accessible and viable option for couples struggling with infertility, representing another major growth-inducing factor. Also, China has seen significant improvements in its healthcare infrastructure, including the establishment of specialized fertility clinics and the training of medical professionals in in vitro fertilization (IVF) techniques, augmenting the market growth. These developments have made in vitro fertilization (IVF) more widely available and reliable. Besides this, the implementation of government policies promotes the growth of in vitro fertilization (IVF) due to the growing population and a declining birth rate are accelerating the market growth. It encourages family planning and supports couples seeking fertility treatments with policies including financial incentives and the removal of certain restrictions, making in vitro fertilization (IVF) more accessible to a broader segment of the population. Along with this, the rise of medical tourism allows couples from neighboring countries, where in vitro fertilization (IVF) procedures may be more expensive or less accessible, to travel to China to undergo fertility treatments, further propelling the market growth. This influx of international patients is escalating the revenue of Chinese fertility clinics and establishing China as a hub for in vitro fertilization (IVF) services in the region.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on product, procedure type, cycle type, and end user.
Product Insights:
The report has provided a detailed breakup and analysis of the market based on the product. This includes reagent (cryopreservation media, embryo culture media, ovum processing media, and sperm processing media), instrument (imaging systems, incubators, cryosystems, IVF cabinet, ovum aspiration pump, sperm separation systems, micromanipulator systems, and others), and accessories.
Procedure Type Insights:
A detailed breakup and analysis of the market based on the procedure type have also been provided in the report. This includes fresh donor, frozen donor, fresh non-donor, and frozen non-donor.
Cycle Type Insights:
The report has provided a detailed breakup and analysis of the market based on the cycle type. This includes conventional IVF, IVF with ICSI, and IVF with donor eggs.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes fertility clinics, hospitals, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North and Northeast, Northwest, East, South Central, and Southwest.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | US$ Million |
Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Products Covered |
|
Procedure Types Covered | Fresh Donor, Frozen Donor, Fresh Non-donor, Frozen Non-donor |
Cycle Types Covered | Conventional IVF, IVF with ICSI, IVF with Donor Eggs |
End Users Covered | Fertility Clinics, Hospitals, Others |
Regions Covered | North and Northeast, Northwest, East, South Central, Southwest |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |